Nateglinide Patent Expiration
Nateglinide is Used for managing blood glucose levels in individuals with diabetes, particularly type 2 diabetes. It was first introduced by Novartis Pharmaceuticals Corp
Nateglinide Patents
Given below is the list of patents protecting Nateglinide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Starlix | US6559188 | Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes |
Sep 15, 2020
(Expired) | Novartis |
| Starlix | US6878749 | Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
Sep 15, 2020
(Expired) | Novartis |
| Starlix | US6641841 | Tablet composition |
Nov 14, 2017
(Expired) | Novartis |
| Starlix | US6844008 | Tablet composition |
Nov 14, 2017
(Expired) | Novartis |
| Starlix | US5488150 | Crystals of N-(trans-4-isopropylcyclohexycarbonyl)-D-phenylalanine and methods for preparing them |
Jan 30, 2013
(Expired) | Novartis |
| Starlix | US5463116 | Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them |
Oct 21, 2012
(Expired) | Novartis |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Nateglinide's patents.
Latest Legal Activities on Nateglinide's Patents
Given below is the list recent legal activities going on the following patents of Nateglinide.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Expire Patent Critical
| 10 May, 2013 | US6878749 |
| Post Issue Communication - Certificate of Correction | 22 Jan, 2008 | US6844008 |
| Case Docketed to Examiner in GAU Critical
| 17 Jul, 2007 | US6844008 |
| Post Issue Communication - Certificate of Correction | 10 Jan, 2007 | US6641841 |
| Patent Issue Date Used in PTA Calculation Critical
| 12 Apr, 2005 | US6878749 |
| Recordation of Patent Grant Mailed Critical
| 12 Apr, 2005 | US6878749 |
| Issue Notification Mailed Critical
| 23 Mar, 2005 | US6878749 |
| Application Is Considered Ready for Issue Critical
| 15 Mar, 2005 | US6878749 |
| Dispatch to FDC | 15 Mar, 2005 | US6878749 |
| Receipt into Pubs | 15 Mar, 2005 | US6878749 |
Nateglinide's Family Patents
